Changes in RBC deformability and oxygen-delivering ability in cold blood cardioplegia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Kuk Hui | - |
dc.contributor.author | Ahn, Chi Bum | - |
dc.contributor.author | Lee, Sung Ho | - |
dc.contributor.author | Noh, Insup | - |
dc.contributor.author | Shin, Eunkyoung | - |
dc.contributor.author | So, Mijin | - |
dc.contributor.author | Kim, Hyuna | - |
dc.contributor.author | Sun, Kyung | - |
dc.contributor.author | Kim, Kwang Taik | - |
dc.date.accessioned | 2021-09-07T21:26:09Z | - |
dc.date.available | 2021-09-07T21:26:09Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 1386-0291 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/114924 | - |
dc.description.abstract | Purpose: The advantages of blood cardioplegia, which is used for myocardial protection during open heart surgeries, include superior oxygen-carrying capacities, better osmotic properties, and the presence of more antioxidants than a crystalloid counterpart. Although, hyperkalemic organ-preserving solutions for transplantation surgeries are known to decrease RBC deformability essential for tissue perfusion, only few studies have addressed the changes in RBC deformability after exposure to cardioplegic additives. The purpose of this study was to measure deformability and oxygen-delivery capacities in various blood cardioplegic solutions. Methods: Blood from eight healthy volunteers was used. Each sample (100 ml) was divided into 5 groups of 16 ml, and cardioplegia solutions were added (group NS; blood + normal saline, group K; blood + KCl, group D; blood + KCl + diltiazem, group A: blood + KCl + adenosine, group E: blood + KCl + neutrophil elastase inhibitor [ Sivelestat]). All samples were incubated at a temperature of 8 degrees C for 10 minutes. Deformability, NO level, 2,3-DPG, and ATP were measured. Results: There was no statistically significant difference (p = 0.92) in deformability between the groups. The NO levels were not significantly different (p = 0.86). The 2,3-DPG (p = 0.27) and ATP levels (p = 0.40) were not significantly different. Conclusions: The deformability and oxygen carrying functions of RBCs did not show a significant difference according to various components of cold blood cardioplegia during 10 minutes of incubation. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | IOS PRESS | - |
dc.subject | NEUTROPHIL ELASTASE INHIBITOR | - |
dc.subject | CELL DEFORMABILITY | - |
dc.subject | REPERFUSION INJURY | - |
dc.subject | NITRIC-OXIDE | - |
dc.subject | HEMORHEOLOGY | - |
dc.subject | PROTECTION | - |
dc.subject | DILTIAZEM | - |
dc.subject | ERYTHROCYTES | - |
dc.subject | PRESERVATION | - |
dc.subject | MAINTENANCE | - |
dc.title | Changes in RBC deformability and oxygen-delivering ability in cold blood cardioplegia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, Chi Bum | - |
dc.contributor.affiliatedAuthor | Lee, Sung Ho | - |
dc.contributor.affiliatedAuthor | Sun, Kyung | - |
dc.contributor.affiliatedAuthor | Kim, Kwang Taik | - |
dc.identifier.doi | 10.3233/CH-2011-1413 | - |
dc.identifier.scopusid | 2-s2.0-80155161499 | - |
dc.identifier.wosid | 000296573800002 | - |
dc.identifier.bibliographicCitation | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, v.48, no.4, pp.223 - 229 | - |
dc.relation.isPartOf | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | - |
dc.citation.title | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | - |
dc.citation.volume | 48 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 223 | - |
dc.citation.endPage | 229 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.relation.journalWebOfScienceCategory | Peripheral Vascular Disease | - |
dc.subject.keywordPlus | NEUTROPHIL ELASTASE INHIBITOR | - |
dc.subject.keywordPlus | CELL DEFORMABILITY | - |
dc.subject.keywordPlus | REPERFUSION INJURY | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.subject.keywordPlus | HEMORHEOLOGY | - |
dc.subject.keywordPlus | PROTECTION | - |
dc.subject.keywordPlus | DILTIAZEM | - |
dc.subject.keywordPlus | ERYTHROCYTES | - |
dc.subject.keywordPlus | PRESERVATION | - |
dc.subject.keywordPlus | MAINTENANCE | - |
dc.subject.keywordAuthor | Erythrocyte deformability | - |
dc.subject.keywordAuthor | extracorporeal circulation | - |
dc.subject.keywordAuthor | 2,3-dipalmitoylglyceric acid | - |
dc.subject.keywordAuthor | microcirculation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.